Anup Shah
NPI: 1285088823
Total Payments
$811.39
2024 Payments
$279.91
Companies
12
Transactions
39
Medicare Patients
1,042
Medicare Billing
$128,049
Payment Breakdown by Category
Food & Beverage$811.39 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $811.39 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $168.17 | 10 | $0 (2024) |
| ABBVIE INC. | $136.98 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $99.27 | 6 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $94.21 | 1 | $0 (2022) |
| PFIZER INC. | $63.31 | 4 | $0 (2024) |
| QOL Medical, LLC | $61.88 | 4 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $58.19 | 1 | $0 (2023) |
| Celgene Corporation | $45.43 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $34.80 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $17.68 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $279.91 | 17 | Janssen Biotech, Inc. ($117.23) |
| 2023 | $314.85 | 17 | Janssen Scientific Affairs, LLC ($58.19) |
| 2022 | $216.63 | 5 | ABBVIE INC. ($107.91) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Immunology | ||||||
| 05/15/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Immunology | ||||||
| 05/02/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Neuroscience | ||||||
| 04/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/08/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Immunology | ||||||
| 03/27/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Immunology | ||||||
| 03/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Immunology | ||||||
| 01/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: Neuroscience | ||||||
| 12/18/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 11/21/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Neuroscience | ||||||
| 11/07/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/21/2023 | PFIZER INC. | XELJANZ (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/10/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Immunology | ||||||
| 09/29/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/31/2023 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $58.19 | General |
| Category: Immunology | ||||||
| 07/25/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 820 | 1,085 | $413,946 | $100,850 |
| 2022 | 7 | 222 | 287 | $84,851 | $27,199 |
Total Patients
1,042
Total Services
1,372
Medicare Billing
$128,049
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 206 | 411 | $69,583 | $26,895 | 38.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 166 | 178 | $76,540 | $25,645 | 33.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 51 | 52 | $68,116 | $10,050 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 125 | $15,000 | $8,639 | 57.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 65 | 65 | $13,650 | $5,508 | 40.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 67 | $74,016 | $5,046 | 6.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 59 | 63 | $41,560 | $4,686 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $8,800 | $4,448 | 50.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 34 | $15,614 | $3,619 | 23.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 14 | $3,542 | $2,777 | 78.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 18 | 19 | $16,062 | $1,957 | 12.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $11,463 | $1,581 | 13.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 130 | $20,256 | $7,717 | 38.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 42 | $18,060 | $6,860 | 38.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 29 | 30 | $16,940 | $3,048 | 18.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 14 | 14 | $17,265 | $2,952 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $6,090 | $2,702 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 30 | $3,600 | $2,345 | 65.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,640 | $1,575 | 59.7% |
About Anup Shah
Anup Shah is a Student in an Organized Health Care Education/Training Program healthcare provider based in Lumberton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1285088823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anup Shah has received a total of $811.39 in payments from pharmaceutical and medical device companies, with $279.91 received in 2024. These payments were reported across 39 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($811.39).
As a Medicare-enrolled provider, Shah has provided services to 1,042 Medicare beneficiaries, totaling 1,372 services with total Medicare billing of $128,049. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Lumberton, NJ
- Active Since 04/20/2016
- Last Updated 12/17/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1285088823
Products in Payments
- STELARA (Biological) $156.32
- SKYRIZI (Biological) $136.98
- KRISTALOSE (Drug) $94.21
- ENTYVIO (Biological) $83.62
- XELJANZ (Drug) $63.31
- TREMFYA (Drug) $54.18
- Sucraid (Drug) $47.37
- ZEPOSIA (Drug) $45.43
- VOQUEZNA (Drug) $34.80
- DUPIXENT (Biological) $17.68
- BRIDION (Drug) $17.00
- REMICADE (Biological) $15.86
- GATTEX (Drug) $15.65
- SUCRAID (Drug) $14.51
- CIMZIA (Drug) $14.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Lumberton
Dr. Temitope Adebayo, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $39,103
Student in an Organized Health Care Education/Training Program $39,103
Hiten Patel, Md/Cardiology, MD/CARDIOLOGY
Student in an Organized Health Care Education/Training Program — Payments: $8,365
Student in an Organized Health Care Education/Training Program $8,365
Dr. Mayank Lahoti, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $2,867
Student in an Organized Health Care Education/Training Program $2,867
Omonigho Nwoke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $570.28
Student in an Organized Health Care Education/Training Program $570.28
Dr. Charles Haddock, Dmd, DMD
Student in an Organized Health Care Education/Training Program — Payments: $404.80
Student in an Organized Health Care Education/Training Program $404.80
Karen Tong, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $267.46
Student in an Organized Health Care Education/Training Program $267.46